NASH - Hepatic metabolism and not simply the metabolic syndrome

Hepatology

Volumn 38, Issue 1, 2003, Pages 14-17

  Green, Richard M ^a  

^a NORTHWESTERN UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACYL COENZYME A DEHYDROGENASE; ADIPONECTIN; ALANINE AMINOTRANSFERASE; ALCOHOL; AMIODARONE; APOLIPOPROTEIN B; CARRIER PROTEIN; CHOLINE; CLOFIBRATE; CYTOCHROME P450; CYTOCHROME P450 4A10; CYTOCHROME P450 4A14; FIBRIC ACID DERIVATIVE; INSULIN; LEPTIN; METHIONINE; METHIONINE ADENOSYLTRANSFERASE 1A; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR AGONIST; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR ALPHA; PHOSPHATIDYLCHOLINE; PHOSPHOETHANOLAMINE METHYL TRANSFERASE; PIRINIXIC ACID; PIRPROFEN; RESISTIN; S ADENOSYLMETHIONINE; TETRACYCLINE; TIANEPTINE; TRIGLYCERIDE TRANSFER PROTEIN; UNCLASSIFIED DRUG; UNINDEXED DRUG; VERY LOW DENSITY LIPOPROTEIN;

ALANINE AMINOTRANSFERASE BLOOD LEVEL; ANIMAL MODEL; CHOLINE DEFICIENT DIET; DIET; DIET SUPPLEMENTATION; DISEASE MARKER; DYSLIPIDEMIA; EDITORIAL; ENVIRONMENTAL FACTOR; FATTY ACID OXIDATION; FATTY LIVER; HYPERGLYCEMIA; HYPERTENSION; INFLAMMATION; INSULIN RESISTANCE; KNOCKOUT MOUSE; LIVER CIRRHOSIS; LIVER FIBROSIS; LIVER METABOLISM; METABOLIC SYNDROME X; MULTIFACTORIAL INHERITANCE; NON INSULIN DEPENDENT DIABETES MELLITUS; NONALCHOHOLIC FATTY LIVER DISEASE; NONALCOHOLIC FATTY LIVER; OBESITY; OVARY POLYCYSTIC DISEASE; PATHOGENESIS; PREVALENCE; PRIORITY JOURNAL; UNITED STATES; VITAMIN DEFICIENCY;

EID: 0037785066     PISSN: 02709139     EISSN: None     Source Type: Journal    
DOI: 10.1053/jhep.2003.50325     Document Type: Editorial

References (36)

1. Brunt EM. Nonalcoholic steatohepatitis: definition and pathology. Semin Liver Dis 2001;21:3-16.
2. Caldwell SH, Oelsner DH, Iezzoni JC, Hespenheide EE, Battle EH, Driscoll CJ. Cryptogenic cirrhosis: clinical characterization and risk factors for underlying disease. HEPATOLOGY 1999;29:664-669.
3. Kuczmarski RJ, Carroll MD, Flegal KM, Troiano RP. Varying body mass index cutoff points to describe overweight prevalence among U.S. adults: NHANES III (1988 to 1994). Obes Res 1997;5:542-548.
4. Marchesini G, Bugianesi E, Forlani G, Cerrelli F, Lenzi M, Manini R, Natale S, et al. Nonalcoholic fatty liver, steatohepatitis, and the metabolic syndrome. HEPATOLOGY 2003;37:917-923.
5. Lakka HM, Laaksonen DE, Lakka TA, Niskanen LK, Kumpusalo E, Tuomilehto J, Salonen JT. The metabolic syndrome and total and cardiovascular disease mortality in middle-aged men. JAMA 2002;288:2709-2716.
6. Chitturi S, Abeygunasekera S, Farrell GC, Holmes-Walker J, Hui JM, Fung C, Karim R, et al. NASH and insulin resistance: insulin hypersecretion and specific association with the insulin resistance syndrome. HEPATOLOGY 2002;35:373-379.
7. Neuschwander-Tetri BA, Caldwell SH. Nonalcoholic steatohepatitis: summary of an AASLD Single Topic Conference. HEPATOLOGY 2003;37:1202-1219.
8. Sanyal AJ, Campbell-Sargent C, Mirshahi F, Rizzo WB, Contos MJ, Sterling RK, Luketic VA, et al. Nonalcoholic steatohepatitis: association of insulin resistance and mitochondrial abnormalities. Gastroenterology 2001;120:1183-1192.
9. Musso G, Gambino R, De Michieli F, Cassader M, Rizzetto M, Durazzo M, Faga E, et al. Dietary habits and their relations to insulin resistance and postprandial lipemia in nonalcoholic steatohepatitis. HEPATOLOGY 2003;37:909-916.
10. Diamanti-Kandarakis E, Mitrakou A, Raptis S, Tolis G, Duleba AJ. The effect of a pure antiandrogen receptor blocker, flutamide, on the lipid profile in the polycystic ovary syndrome. J Clin Endocrinol Metab 1998;83:2699-2705.
11. Ip E, Farrell GC, Robertson G, Hall P, Kirsch, Leclerq E. Central role of PPAR-α-dependent hepatic lipid turnover in dietary steatohepatitis in mice. HEPATOLOGY 2003;38:123-132.
12. Letteron P, Sutton A, Mansouri A, Fromenry B, Pessayre. Inhibition of microsomal triglyceride transfer protein: another mechanism for drug-induced steatosis in mice. HEPATOLOGY 2003;38:133-140.
13. Leclercq IA, Farrell GC, Field J, Bell DR, Gonzalez FJ, Robertson GR. CYP2E1 and CYP4A as microsomal catalysts of lipid peroxides in murine nonalcoholic steatohepatitis. J Clin Invest 2000;105:1067-1075.
14. Vance DE, Vance J. Glycerolipid biosynthesis in eukaryotes. In: Vance DE, Vance J, eds. Biochemistry of Lipids, Lipoproteins and Membranes. New York: Elsevier Science, 1996:153-181.
15. Walkey CJ, Yu L, Agellon LB, Vance DE. Biochemical and evolutionary significance of phospholipid methylation. J Biol Chem 1998;273:27043-27046.
16. Vance D, Walkey C. Roles for the methylation of phosphatidylethanolamine. Cur Opin Lipid 1998;9:125-130.
17. Walkey CJ, Yu L, Agellon LB, Vance DE. Biochemical and evolutionary significance of phospholipid methylation. J Biol Chem 1998;273:27043-27046.
18. Chawla RK, Watson WH, Eastin CE, Lee EY, Schmidt J, McClain CJ. S-adenosylmethionine deficiency and TNF-alpha in lipopolysaccharide-induced hepatic injury. Am J Physiol 1998;275(Part 1):G1259.
19. Lu SC, Alvarez L, Huang ZZ, Chen L, An W, Corrales FJ, Avila MA, et al. Methionine adenosyltransferase 1A knockout mice are predisposed to liver injury and exhibit increased expression of genes involved in proliferation. Proc Natl Acad Sci U S A 2001;98:5560-5565.
20. Martinez-Chantar ML, Corrales FJ, Martinez-Cruz LA, Garcia-Trevijano ER, Huang ZZ, Chen L, Kanel G, et al. Spontaneous oxidative stress and liver tumors in mice lacking methionine adenosyltransferase 1A. FASEB J 2002;16:1292-1294.
21. Hashimoto T, Fujita T, Usuda N, Cook W, Qi C, Peters JM, Gonzalez FJ, et al. Peroxisomal and mitochondrial fatty acid beta-oxidation in mice nullizygous for both peroxisome proliferator-activated receptor alpha and peroxisomal fatty acyl-CoA oxidase. Genotype correlation with fatty liver phenotype. J Biol Chem 1999;274:19228-19236.
22. Hashimoto T, Cook WS, Qi C, Yeldandi AV, Reddy JK, Rao MS. Defect in peroxisome proliferator-activated receptor alpha-inducible fatty acid oxidation determines the severity of hepatic steatosis in response to fasting. J Biol Chem 2000;275:28918-28928.
23. Kok T, Wolters H, Bloks VW, Havinga R, Jansen PL, Staels B, Kuipers F. Induction of hepatic ABC transporter expression is part of the PPARalpha-mediated fasting response in the mouse. Gastroenterology 2003:124:160-171.
24. Koteish A, Diehl AM. Animal models of steatosis. Semin Liver Dis 2001;21:89-104.
25. Leclercq IA, Farrell GC, Schriemer R, Robertson GR. Leptin is essential for the hepatic fibrogenic response to chronic liver injury. J Hepatol 2002;37:206-213.
26. Saxena NK, Saliba G, Floyd JJ, Anania FA. Leptin induces increased alpha2 (I) collagen gene expression in cultured rat hepatic stellate cells. J Cell Biochem 2003;89:311-320.
27. Honda H, Ikejima K, Hirose M, Yoshikawa M, Lang T, Enomoto N, Kitamura T, et al. Leptin is required for fibrogenic responses induced by thioacetamide in the murine liver. HEPATOLOGY 2002;36:12-21.
28. VanPatten S, Ranginani N, Shefer S, Nguyen LB, Rossetti L, Cohen DE. Impaired biliary lipid secretion in obese Zucker rats: leptin promotes hepatic cholesterol clearance. Am J Physiol Gastrointest Liver Physiol 2001;281:G393-G404.
29. Hyogo H, Roy S, Paigen B, Cohen DE. Leptin promotes biliary cholesterol elimination during weight loss in ob/ob mice by regulating the enterohepatic circulation of bile salts. J Biol Chem 2002;277:34117-341124.
30. Hyogo H, Roy S, Cohen DE. Restoration of Gallstone Susceptibility by Leptin in C57BL/6J ob/ob Mice. J Lipid Res 2003 Apr 1. [epub ahead of print]
31. Eastin CE, McClain CJ, Lee EY, Bagby GJ, Chawla RK. Choline deficiency augments and antibody to tumor necrosis factor-α attenuates endotoxin-induced hepatic injury. Alcohol Clin Exp Res 1997;21:1037-1041.
32. McClain CJ, Hill DB, Song Z, Chawla R, Watson WH, Chen T, Barve S. S-Adenosylmethionine, cytokines, and alcoholic liver disease. Alcohol 2002;27:185-192.
33. Rinella ME, Green RM. The Methionine-Choline Deficient (MCD) diet of NASH is associated with hypoglycemia and diminished serum insulin levels [abstract]. HEPATOLOGY 2002;36(Part 2):402A.
34. Cohen P, Miyazaki M, Socci ND, Hagge-Greenberg A, Liedtke W, Soukas AA, Sharma R, et al. Role for stearoyl-CoA desaturase-1 in leptin-mediated weight loss. Science 2002;12:240-243.
35. Ntambi JM, Miyazaki M, Stoehr JP, Lan H, Kendziorski CM, Yandell BS, Song Y, et al. Loss of stearoyl-CoA desaturase-1 function protects mice against adiposity. Proc Natl Acad Sci U S A 2000;99:11482-11486.
36. Wang YX, Lee CH, Tiep S, Yu RT, Ham J, Kang H, Evans RM. Peroxisome-proliferator-activated receptor delta activates fat metabolism to prevent obesity. Cell 2003;113:159-170.